Articles In Academic Journals

Filter

Year	Title
2016	Galeterone and VNPT55 disrupts Mnk-eIF4E to inhibit prostate cancer cell migration and invasion..  The FEBS journal.
2014	VN/14-1 induces ER stress and autophagy in HP-LTLC human breast cancer cells and has excellent oral pharmacokinetic profile in female Sprague Dawley rats..  European journal of pharmacology. 98-104.
2011	CYP17 inhibitors for prostate cancer therapy..  The Journal of steroid biochemistry and molecular biology. 23-31.
2011	Synthesis and biological evaluations of putative metabolically stable analogs of VN/124-1 (TOK-001): head to head anti-tumor efficacy evaluation of VN/124-1 (TOK-001) and abiraterone in LAPC-4 human prostate cancer xenograft model..  Steroids. 1268-79.
2008	17alpha-Hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response..  Molecular cancer therapeutics. 2828-36.
2008	Potent anti-prostate cancer agents derived from a novel androgen receptor down-regulating agent..  Bioorganic & medicinal chemistry. 3519-29.
2007	First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents..  Bioorganic & medicinal chemistry. 3413-21.
2007	Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development..  Bioorganic & medicinal chemistry. 5047-60.